SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Arterial Vascular Engineering AVEI -- Ignore unavailable to you. Want to Upgrade?


To: tom r. phillips who wrote (334)9/18/1998 2:10:00 PM
From: Dave Chanoux  Respond to of 410
 
Value Line initiated coverage of AVEI in their September 11 issue. The Value Line system, which is price and earnings momentum based, rates AVEI as #1 (of 5), its top rating for year ahead performance.

The report's narrative points out the company's relatively low P/E compared to others in the industry, the two pending acquisitions, competitive factors in the industry, and expected price declines as a result of new entries.

Regards,

Dave Chanoux